1Steinhoff H,Lanksch W,Kazner E. Computed tomography in the diagnosis and differential diagnosis of glioblastomas[J].A qualitative study of 295 cases Neuroradiology,1977.193-200.
2Wilson CB. Chemotherapy of brain tumors[J].Advances in Neurology,1976.361-367.
3Walker MD,Green SB,Byar DP. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery[J].New England Journal of Medicine,1980.1323-1329.
4Walker MD,Alexander E Jr,Hunt WE. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas[J].A cooperative clinical trial J Neurosurg,1978.333-343.
5Fine HA,Dear KB,Loeffler JS. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults[J].Cancer,1993.2585-2597.
6Louis DN,Ohgaki H,Wiestler OD. The 2007 WHO classification of tumours of the central nervous system[J].Acta Neuropathologica,2007.97-109.
7Grossman SA,Fisher JD,Piantadosi S. The New Approaches to Brain Tumor Therapy(NABTT)CNS Consortium:Organization,Objectives,and Activities[J].Cancer Control:Journal of the Moffitt Cancer Center,1998.107-114.
8Stupp R,Mason WP,van den Bent MJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J].New England Journal of Medicine,2005.987-996.
9Westphal M,Hilt DC,Bortey E. A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU)wafers(Gliadel wafers)in patients with primary malignant glioma[J].Journal of Neuro-Oncology,2003.79-88.
10Hegi ME,Diserens AC,Gorlia T. MGMT gene silencing and benefit from temozolomide in glioblastoma[J].New England Journal of Medicine,2005.997-1003.
